title: Recent advances in the understanding of the processing of APP to beta amyloid peptide.
authors.affiliation: Elan Pharmaceuticals, 800 Gateway Blvd., So. San Francisco, CA 94080, USA. ssinha@elanpharma.com
authors.forename: S
authors.initials: S
authors.lastname: Sinha
authors.forename: J
authors.initials: J
authors.lastname: Anderson
authors.forename: V
authors.initials: V
authors.lastname: John
authors.forename: L
authors.initials: L
authors.lastname: McConlogue
authors.forename: G
authors.initials: G
authors.lastname: Basi
authors.forename: E
authors.initials: E
authors.lastname: Thorsett
authors.forename: D
authors.initials: D
authors.lastname: Schenk
mesh_terms: D000544:Alzheimer Disease / Q000378:metabolism; D053829:Amyloid Precursor Protein Secretases; D016229:Amyloid beta-Peptides / Q000378:metabolism*; D016564:Amyloid beta-Protein Precursor / Q000378:metabolism*; D016282:Aspartic Acid Endopeptidases; D001921:Brain / Q000201:enzymology*; D010450:Endopeptidases / Q000378:metabolism*; D006801:Humans; D011499:Protein Processing, Post-Translational; D011994:Recombinant Proteins / Q000378:metabolism
chemical_list: D016229:Amyloid beta-Peptides; D016564:Amyloid beta-Protein Precursor; D011994:Recombinant Proteins; D053829:Amyloid Precursor Protein Secretases; D010450:Endopeptidases; D016282:Aspartic Acid Endopeptidases; C509280:BACE1 protein, human